- Home
- PLRX vs SRTS Comparison
PLRX vs SRTS Comparison
Compare PLRX & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | SRTS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 79.3M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PLRX | SRTS |
|---|---|---|
| Price | $1.27 | $5.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $3.79 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 1.0M | 122.2K |
| Earning Date | 03-02-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $3.03 |
| 52 Week High | $12.88 | $9.08 |
Technical Indicators
Market Signals| Indicator | PLRX | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 61.62 |
| Support Level | $1.26 | $4.64 |
| Resistance Level | $1.36 | $5.36 |
| Average True Range (ATR) | 0.06 | 0.38 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 17.86 | 62.18 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.